July 15, 2010
BioForm Medical has launched Asclera (polidocanol injection), a sclerotherapy treatment.
May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
April 07, 2010
The FDA has issued warning letters to six medical spas for making false or misleading statements on their websites about drugs they claim will eliminate fat in a procedure called "lipodissolve," or for otherwise misbranding lipodissolve products.
March 31, 2010
EvoLife Laboratories has launched its product line of skin, oral, nail, hair, hygiene care for cancer patients undergoing chemotherapy and radiotherapy.
March 31, 2010
The FDA has approved Asclera (polidocanol injection, from BioForm Medical) for the treatment of small types of abnormally swollen or twisted veins called varicose veins.